Clinical Study Demonstrates Improvement in Injection Recovery with Topical Use of Alastin's INhance

Posted By American Med Spa Association, Thursday, June 11, 2020

Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products, has announced the publication of a clinical study highlighting its most recent product, INhance post-injection serum with TriHex Technology. The Journal of Drugs in Dermatology (JDD)—the peer-reviewed publication authored by Alan D. Widgerow, MBBCh, MMed (Plast), FCS, Carolyn Jacob, MD, and Melanie D. Palm, MD, MBA—reviews the science behind the product and demonstrates the clinical utility of combining a topical adjunct with injectable procedures.
Read more at PR Newswire >>